Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Managlinat dialanetil (MB06322) is an orally available and potent fructose 1,6-bisphosphatase (FBPase) inhibitor with hypoglycaemic activity for the study of type 2 diabetes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 233.00 | |
5 mg | In stock | $ 578.00 | |
10 mg | In stock | $ 919.00 | |
25 mg | In stock | $ 1,380.00 | |
50 mg | In stock | $ 1,860.00 | |
100 mg | In stock | $ 2,490.00 | |
500 mg | In stock | $ 4,930.00 |
Description | Managlinat dialanetil (MB06322) is an orally available and potent fructose 1,6-bisphosphatase (FBPase) inhibitor with hypoglycaemic activity for the study of type 2 diabetes. |
In vivo | Dose-dependently inhibiting gluconeogenesis (GNG), managlinat dialanetil also lowers basal and postprandial blood glucose levels in Zucker diabetic fatty (ZDF) rats after oral administration[1]. |
Synonyms | MB06322, MB 6322, CS-917 |
Molecular Weight | 500.55 |
Formula | C21H33N4O6PS |
CAS No. | 280782-97-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL (39.96 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Managlinat dialanetil 280782-97-0 Metabolism Phosphatase MB06322 MB 6322 CS-917 inhibitor inhibit